The Ri.MED Foundation is a public-private partnership founded by the Italian Government, UPMC, University of Pittsburgh, CNR, and Sicily Region, integrated with the transplant hospital ISMETT.

The Foundation, based in Palermo, promotes, supports and leads biomedical and biotechnological research projects, with emphasis on the translation of innovative results into clinical practice.

Ri.MED is currently finalizing a cutting-edge Research Center in Sicily, 17.000 mq of laboratories focused on organs, therapies, and the human-environment link in a one-health perspective.

At the same time, the Foundation trains the researchers who will provide the human capital of the Research Centre.

Ri.MED leads translational research in bioengineering, drug discovery, and regenerative medicine, securing over €20M in grants.

In preclinical and clinical research, strategic are the partnerships with the University of Pittsburgh, UPMC and IRCCS-ISMETT, which have yielded proprietary intellectual property resulting in several joint patent applications.

The generation of intellectual property represents a fundamental intangible asset in the valorization of the Fondazione Ri.MED, with the perspective of developing an innovative model of sustainable research.